Swiss Re Insurance-Linked Fund Management

Original Risk: A Society for Change Agents

No change to Vitality Re VI price guidance yet


According to sources, the price guidance for the latest health insurance-linked security (ILS) from Aetna, Vitality Re VI Ltd. (Series 2015-1), has not changed as the transaction approaches completion.

Investor sources told Artemis that the sixth Vitality Re medical benefit ratio linked ILS deal from Aetna has not seen a tightening of guidance or any change in the range that the deal launched with as yet. In fact the deal’s bookrunner Goldman Sachs is said to have reiterated the launch guidance to investors today.

The notes continue to be marketed to investors with the Class A notes offered with a coupon range of 1.65% to 2.15%, while the riskier Class B notes continue to be offered with guidance of 2.25% to 2.75%.

The Vitality Re VI transaction is slated to price early this week. We will update you as and when further updates become available and as the transaction reaches completion.

Read all about this transaction in the Artemis Deal Directory entry, Vitality Re VI Ltd. (Series 2015-1), and in our previous articles covering its launch:

Aetna launches new Vitality Re VI health insurance linked ILS.

S&P explains volatility in Vitality Re ILS, but pandemic remains the tail.

Register today for ILS NYC 2023, our next insurance-linked securities (ILS) market conference. Held in New York City, February 10th, 2023.

Artemis ILS NYC 2023 - Insurance-linked securities conference in New York City

Get a ticket soon to ensure you can attend. Secure your place at the event here!

Print Friendly, PDF & Email

Artemis Newsletters and Email Alerts

Receive a regular weekly email newsletter update containing all the top news stories, deals and event information

  • This field is for validation purposes and should be left unchanged.

Receive alert notifications by email for every article from Artemis as it gets published.